ProfileGDS5822 / ILMN_2892227
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 91% 96% 95% 94% 96% 93% 95% 95% 95% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1573.991
GSM1276600PDAC Late Ablation Control 21571.896
GSM1276601PDAC Late Ablation Control 31373.895
GSM1276602PDAC Late Ablation 1880.394
GSM1276603PDAC Late Ablation 21730.296
GSM1276604PDAC Late Ablation 3976.993
GSM1303940PDAC Late Ablation_anti-CTLA4 11145.295
GSM1303941PDAC Late Ablation_anti-CTLA4 21283.995
GSM1303942PDAC Late Ablation_anti-CTLA4 31294.395